Cytodyn Inc (CYDY)

[The Lawman]

Darned right! Pourhassan should be replaced IMMEDIATELY. There is a huge difference between trying hard and succeeding. If you listen to the update conference calls run by Pourhassan, or speak with him directly,and I have done both, you must come to the conclusion that he is in way over his head. For the millions per year Pourhassan is paid, Cytodyn could get a seasoned executive wih a history of success in bringing clinical stage biopharma companies to the finish line. If you think with your wallet,rather than your heart, you must agree that Cytodyn should replace Pourhassan now.